ARTIC ICE ANALGESIC GEL 2.5% 2.5 %
MENTHOL : 2.5 % · DIN 01915126 · SCOTT CHEMICAL CANADA
Health Canada status: CANCELLED POST MARKET
What is ARTIC ICE ANALGESIC GEL 2.5%?
ARTIC ICE ANALGESIC GEL 2.5% 2.5 % contains MENTHOL : 2.5 %. It is listed in the Health Canada Drug Product Database under DIN 01915126, held by SCOTT CHEMICAL CANADA, supplied as GEL for TOPICAL administration. Health Canada currently lists it as cancelled post market, status dated 26-Aug-2009. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 01915126 |
|---|---|
| Brand name | ARTIC ICE ANALGESIC GEL 2.5% |
| Generic / active ingredient | MENTHOL : 2.5 % |
| Manufacturer | SCOTT CHEMICAL CANADA |
| Strength | 2.5 % |
| Dosage form | GEL |
| Route of administration | TOPICAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | M02AX10 VARIOUS |
| AHFS class | 84:24.04 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 26-Aug-2009 |
| Original market date | 1998-10-28 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code M02AX10 VARIOUS. 0 of 59 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ABSORBINE JR EXTRA STRENGTH LINIMENT | 0.5 % | LIQUID | BRIDGES CONSUMER HEALTHCARE LLC | CANCELLED POST MARKET | DIN 01942271 |
| ABSORBINE JR LINIMENT | 1.25 % | SOLUTION | BRIDGES CONSUMER HEALTHCARE LLC | CANCELLED POST MARKET | DIN 01942301 |
| ABSORBINE POWER GEL | 4 % | GEL | W.F. YOUNG, INC. | DORMANT | DIN 01999524 |
| ANTIPHLOGISTINE RUB A-535 ICE GEL 4% | 4 % | GEL | CARTER PRODUCTS, DIVISION OF CARTER WALLACE NS INC. | CANCELLED POST MARKET | DIN 02034417 |
| ARTHRO RHEUMA CREAM | 1.5 % | CREAM | NATURLAND LTD. | CANCELLED POST MARKET | DIN 02240103 |
| BALMINIL CAMPHORUB | 6.5 % | OINTMENT | ROUGIER PHARMA DIVISION OF RATIOPHARM INC | CANCELLED POST MARKET | DIN 02233025 |
| BEN-GAY ICE | 2.5 % | GEL | PFIZER CANADA INC., CONSUMER HEALTHCARE DIVISION | CANCELLED POST MARKET | DIN 02230265 |
| BENGAY EXTRA STRENGTH ICE | 100 MG | CREAM | PFIZER CANADA INC., CONSUMER HEALTHCARE DIVISION | CANCELLED POST MARKET | DIN 02241251 |
| BIOFREEZE | 0.2 % | GEL | PERFORMANCE HEALTH INC. | CANCELLED POST MARKET | DIN 02237710 |
| BLUE ICE 2.5% | 2.5 % | GEL | LABORATOIRES DELON (1990) INC | CANCELLED POST MARKET | DIN 02244600 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.